Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects.

Monotherapy Polypharmacy Randomized controlled trial Schizophrenia Side effects Switching

Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 17 11 2023
revised: 23 08 2024
accepted: 03 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 17 9 2024
Statut: aheadofprint

Résumé

This study examined the effects of switching antipsychotic polypharmacy (APP) to antipsychotic monotherapy (APM) on various side effects in inpatients with schizophrenia. Side effects of interest included psychic, autonomic, and sexual symptoms, as well as metabolic side effects and movement disorders. A 9-month parallel randomized open-label clinical trial was conducted involving 136 chronic inpatients from two psychiatric hospitals in the Netherlands. Participants were randomly assigned to either a STAY or a SWITCH group. The SWITCH group underwent a 3-month tapering-off period in which either first-generation or second-generation antipsychotic medication was discontinued, followed by APM. Patients were assessed at baseline and at follow-up assessments at 3, 6, and 9 months. Psychic, neurological, autonomic, and sexual side effects were evaluated using the UKU Rating Scale, while movement disorders were measured with the St. Hans Rating Scale. Various metabolic parameters were also recorded. In the STAY group, side effects remained generally stable over time, except for a slight reduction in sexual desire. In contrast, the SWITCH group experienced significant reductions in psychic and autonomic symptoms, as well as improvements in akathisia, parkinsonism, and dyskinesia. There were no changes in dystonia, paresthesia, epilepsy, or sexual symptoms for this group. Notably, the SWITCH group also showed significant reductions in BMI and body weight. Switching APP to APM in long-term inpatients reduces the severity of various side effects, including movement disorders and metabolic side effects.

Identifiants

pubmed: 39288473
pii: S0920-9964(24)00407-9
doi: 10.1016/j.schres.2024.09.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-112

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mushde Shakir (M)

Veldzicht Center for Transcultural Psychiatry, Custodial Institutions Agency (DJI), Ministry of Justice and Security, Balkbrug, the Netherlands; Parnassia Group Mental Health Service, Den Haag, the Netherlands; Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Faculty Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands. Electronic address: mujde_mahmud@hotmail.com.

Peter N van Harten (PN)

Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Faculty Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands; GGZ Centraal Mental Health Service, Amersfoort, the Netherlands.

Adriaan W Hoogendoorn (AW)

Department of Psychiatry, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands; Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.

Anne E Willems (AE)

Kenniscentrum Phrenos, the Netherlands.

Diederik E Tenback (DE)

Veldzicht Center for Transcultural Psychiatry, Custodial Institutions Agency (DJI), Ministry of Justice and Security, Balkbrug, the Netherlands; FPC de Oostvaarderskliniek, Custodial Institutions Agency (DJI), Ministry of Justice and Security, Almere, the Netherlands.

Classifications MeSH